Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 16, 2022

SELL
$1.06 - $2.68 $57,621 - $145,684
-54,360 Closed
0 $0
Q4 2021

Feb 14, 2022

BUY
$2.5 - $5.19 $135,900 - $282,128
54,360 New
54,360 $136,000
Q2 2020

Aug 12, 2020

SELL
$13.68 - $20.46 $341,562 - $510,845
-24,968 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$14.83 - $26.72 $299,654 - $539,904
-20,206 Reduced 44.73%
24,968 $387,000
Q4 2019

Feb 18, 2020

SELL
$9.77 - $24.6 $389,139 - $979,818
-39,830 Reduced 46.86%
45,174 $1.11 Million
Q3 2019

Nov 14, 2019

SELL
$10.17 - $13.86 $235,862 - $321,441
-23,192 Reduced 21.44%
85,004 $877,000
Q2 2019

Aug 14, 2019

BUY
$11.43 - $15.12 $1.24 Million - $1.64 Million
108,196 New
108,196 $1.36 Million

About Epizyme, Inc.


  • Ticker EPZM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 168,364,992
  • Market Cap $247M
More about EPZM
Track This Portfolio

Track Algert Global LLC Portfolio

Follow Algert Global LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Algert Global LLC, based on Form 13F filings with the SEC.

News

Stay updated on Algert Global LLC with notifications on news.